Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Beckman to Take Over Sales of Access System

By HospiMedica staff writers
Posted on 25 Sep 2000
The sales of the Access immunoassay instrument system and test kits in 90 markets in Europe, Africa, and the Pacific Rim will be taken over by owner Beckman Coulter (Fullerton, CA, USA), the company has announced. More...
Beckman decided not to renew its distribution contract for Access with Bio-Rad Laboratories. The Access business was purchased by Beckman Coulter in 1997 from Pasteur Sanofi Diagnostics (PSD), which became the distributor of the product at that time. Later, Bio-Rad acquired Sanofi and took over the distribution.

In order for Beckman Coulter to leverage our strength in total laboratory workflow and to optimize the value it creates for our customers, our conversations with Bio-Rad have led to the conclusion that it is in the best interest of both companies not to renew the agreement, said John P. Wareham, chairman, president, and CEO of Beckman Coulter.

The Access system is a random-access benchtop analyzer that performs a variety of assays, including test panels for cancer, anemia, cardiac problems, and infectious diseases. Separate research and development partnerships and contract manufacturing agreements are not affected by this decision and will be continued, said Beckman Coulter.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.